Evidence map›Paper›PMID 28721305›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2017

Fully automated GMP production of [

Irina Velikyan, Ulrika Rosenstrom, Olof Eriksson

Open access · greenAbstract read
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Towards Optimal AutomatedJournal of labelled compounds & radiopharmaceuticals · 2024
    Article
  3. Fully automated radiolabeling of [EJNMMI radiopharmacy and chemistry · 2023
    Article
  4. Review
  5. Good practices forEJNMMI radiopharmacy and chemistry · 2022
    Review
  6. Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  7. Article
  8. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Article
  11. Automated GMP-Compliant Production of [Pharmaceuticals (Basel, Switzerland) · 2020
    Article
  12. Review
  13. Article
  14. Molecular imaging of β-cells: diabetes and beyond.Advanced drug delivery reviews · 2019
    Review
  15. Diagnostic HER2-binding radiopharmaceutical, [American journal of nuclear medicine and molecular imaging · 2019
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Irina VelikyanDepartment of Medicinal Chemistry, Uppsala UniversityUppsala, Sweden.
Ulrika RosenstromDepartment of Medicinal Chemistry, Uppsala UniversityUppsala, Sweden.
Olof ErikssonDepartment of Medicinal Chemistry, Uppsala UniversityUppsala, Sweden.
Uppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[

Indexed as

automationExendin-4Gallium-68GLP-1GMPInsulinoma

Identifiers

PMID28721305
PMCPMC5511121
OpenAlexW2775482265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.